Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
46.75T | 45.10T | 37.15T | 31.38T | 27.21T | 29.93T | Gross Profit |
9.50T | 9.37T | 6.31T | 5.97T | 4.83T | 5.41T | EBIT |
4.79T | 5.35T | 3.67T | 3.00T | 2.96T | 2.44T | EBITDA |
7.02T | 8.39T | 5.19T | 4.82T | 4.61T | 4.13T | Net Income Common Stockholders |
5.10T | 4.94T | 2.45T | 2.85T | 2.25T | 2.04T |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
13.88T | 14.11T | 9.23T | 8.62T | 9.32T | 5.70T | Total Assets |
94.67T | 90.11T | 74.30T | 67.69T | 62.27T | 52.68T | Total Debt |
39.58T | 36.56T | 29.38T | 26.50T | 25.66T | 20.55T | Net Debt |
31.29T | 27.15T | 21.86T | 20.38T | 20.56T | 16.36T | Total Liabilities |
57.82T | 54.87T | 45.04T | 40.53T | 37.98T | 31.94T | Stockholders Equity |
35.91T | 34.22T | 28.34T | 26.25T | 23.40T | 20.06T |
Cash Flow | Free Cash Flow | ||||
-1.60T | -842.02B | -750.76B | -107.63B | -1.04T | -4.49B | Operating Cash Flow |
4.24T | 4.21T | 2.96T | 3.72T | 2.73T | 3.59T | Investing Cash Flow |
-4.29T | -5.00T | -1.60T | -577.50B | -4.68T | -3.15T | Financing Cash Flow |
391.01B | 2.50T | -56.18B | -2.47T | 2.74T | 397.14B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $219.94B | 6.82 | 14.59% | 2.58% | -0.59% | 7.56% | |
75 Outperform | $23.50B | 22.37 | 12.29% | ― | 15.50% | -32.48% | |
74 Outperform | $43.41B | 6.85 | 9.44% | 1.02% | 9.08% | -15.25% | |
74 Outperform | $48.25B | 7.00 | 8.11% | 4.01% | 4.37% | 6.93% | |
74 Outperform | $916.55B | 156.70 | 9.16% | ― | 1.03% | -53.71% | |
73 Outperform | $37.10B | 6.38 | 13.42% | 7.47% | 5.00% | 35.92% | |
60 Neutral | $6.85B | 11.57 | 3.09% | 4.18% | 2.37% | -21.38% |